We next evaluated whether the tumor growth inhibition observed in Ackr2-targeted B16-F10 cells is associated with changes in immune cell infiltration, likely driven by altered availability of key chemokines such as CCL5 and CXCL10. The gene discussed is ACKR2; the disease is neoplasm.